Literature DB >> 2666306

Chemical composition and tissue distribution of the human CDw44 glycoprotein.

B F Flanagan1, R Dalchau, A K Allen, A S Daar, J W Fabre.   

Abstract

The CDw44 glycoprotein was purified from 2.3 x 10(11) CD3+ CD4+ CD8- T-chronic lymphocytic leukaemia (CLL) cells using F10-44-2 monoclonal antibody affinity chromatography, DEAE-Sepharose anion-exchange chromatography, passage down carboxymethyl (CM)-Sepharose cation-exchange columns, wheat germ lectin affinity chromatography and gel-permeation chromatography. On elution in non-ionic detergents from the DEAE column, two distinct peaks of antigen activity were obtained. The CDw44 glycoprotein in each peak was a glycoprotein of 85,000 MW, but the amino acid composition of the peaks was noticeably different. Carbohydrate compositions showed that each peak contained approximately 30% (w/w) carbohydrate, the composition suggesting both O-linked and complex N-linked glycans. Modulation studies with the F10-44-2 antibody on normal peripheral blood mononuclear cells (PBMC) demonstrated that the CDw44 glycoprotein of T cells consisted of one fraction that was readily modulated, and the other which was resistant to modulation. Detailed tissue distribution studies for CDw44 were performed using the F10-44-2 antibody on frozen sections of human tissues. CDw44 has a restricted tissue distribution, but is found on many highly diverse cell types (e.g. T lymphocytes, smooth muscle cells, some secretory glands, skin epithelial cells).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2666306      PMCID: PMC1385252     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  The quantitation of glucosamine and galactosamine in glycoproteins after hydrolysis in p-toluenesulphonic acid.

Authors:  A K Allen; A Neuberger
Journal:  FEBS Lett       Date:  1975-12-01       Impact factor: 4.124

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man.

Authors:  S T Jalkanen; R F Bargatze; L R Herron; E C Butcher
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

4.  The predominant heavily glycosylated glycoproteins at the surface of rat lymphoid cells are differentiation antigens.

Authors:  R Standring; W R McMaster; C A Sunderland; A F Williams
Journal:  Eur J Immunol       Date:  1978-12       Impact factor: 5.532

5.  Separation of blood leucocytes, granulocytes and lymphocytes.

Authors:  A Boyum
Journal:  Tissue Antigens       Date:  1974

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Purification of the glycoprotein lectin from the broad bean (Vicia faba) and a comparison of its properties with lectins of similar specificity.

Authors:  A K Allen; N N Desai; A Neuberger
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

8.  Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation.

Authors:  B F Haynes; E A Harden; M J Telen; M E Hemler; J L Strominger; T J Palker; R M Scearce; G S Eisenbarth
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

9.  Monoclonal antibody to a human brain-granulocyte-T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat.

Authors:  R Dalchau; J Kirkley; J W Fabre
Journal:  Eur J Immunol       Date:  1980-10       Impact factor: 5.532

10.  Species heterogeneity in macrophage expression of the CD4 antigen.

Authors:  P R Crocker; W A Jefferies; S J Clark; L P Chung; S Gordon
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

View more
  24 in total

1.  New monoclonal antibodies in CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues.

Authors:  D J Anstee; B Gardner; F A Spring; C H Holmes; K L Simpson; S F Parsons; G Mallinson; S M Yousaf; P A Judson
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

2.  Role of CD44 and its v7 isoform in staphylococcal enterotoxin B-induced toxic shock: CD44 deficiency on hepatic mononuclear cells leads to reduced activation-induced apoptosis that results in increased liver damage.

Authors:  Robert J McKallip; Michael Fisher; Ursula Gunthert; Andras K Szakal; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.

Authors:  Yoon Mee Yang; Zhijun Wang; Michitaka Matsuda; Ekihiro Seki
Journal:  Arch Pharm Res       Date:  2021-01-24       Impact factor: 4.946

4.  Expression of CD44 isoforms during bleomycin-or radiation-induced pulmonary fibrosis in rats and mini-pigs.

Authors:  M Kasper; A Bierhaus; A Whyte; R M Binns; D Schuh; M Müller
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

Review 5.  Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system.

Authors:  G H Baltuch; N de Tribolet; E G Van Meir
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

6.  CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma.

Authors:  S Gunia; S Hussein; D L Radu; K M Pütz; R Breyer; H Hecker; M Samii; G F Walter; A C Stan
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

7.  Isolation and characterization of the soluble and membrane-bound porcine CD44 molecules.

Authors:  H Yang; R M Binns
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

8.  Interferon-alpha 2a increases serum concentration of hyaluronic acid and type III procollagen aminoterminal propeptide in patients with chronic hepatitis B virus infection.

Authors:  G Zöhrens; T Armbrust; K H Meyer Zum Büschenfelde; G Ramadori
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

9.  CD44 microbeads accelerate HIV-1 infection in T cells.

Authors:  Valeri H Terry; Ian C D Johnston; Celsa A Spina
Journal:  Virology       Date:  2009-04-23       Impact factor: 3.616

Review 10.  Cell adhesion receptor expression during melanoma progression and metastasis.

Authors:  I R Hart; M Birch; J F Marshall
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.